Sae Rin Jean - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sae Rin Jean

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple MyelomaMark A Schroeder, Mark A Fiala, Eric Huselton, et al.

Molecular Cancer Therapeutics|July 29, 2016

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant OsteosarcomaIlaria Buondonno, Elena Gazzano, Sae Rin Jean, et al.

EMBO Reports|February 14, 2018

Mitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2<sup>S</sup> short isoformShar-Yin N Huang, Ilaria Dalla Rosa, Stephanie A Michaels, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple MyelomaMark A Schroeder, Mark A Fiala, Eric Huselton, et al.

Molecular Cancer Therapeutics|July 29, 2016

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant OsteosarcomaIlaria Buondonno, Elena Gazzano, Sae Rin Jean, et al.

EMBO Reports|February 14, 2018

Mitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2<sup>S</sup> short isoformShar-Yin N Huang, Ilaria Dalla Rosa, Stephanie A Michaels, et al.

Pageof 2